These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20652058)
1. Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction. Fardin P; Cornero A; Barla A; Mosci S; Acquaviva M; Rosasco L; Gambini C; Verri A; Varesio L J Biomed Biotechnol; 2010; 2010():878709. PubMed ID: 20652058 [TBL] [Abstract][Full Text] [Related]
2. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines. Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Varesio L BMC Genomics; 2009 Oct; 10():474. PubMed ID: 19832978 [TBL] [Abstract][Full Text] [Related]
3. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Versteeg R; Caron HN; Molenaar JJ; Ora I; Eva A; Puppo M; Varesio L Mol Cancer; 2010 Jul; 9():185. PubMed ID: 20624283 [TBL] [Abstract][Full Text] [Related]
4. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients. Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905 [TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in ARE-driven gene expression by use of a noise-filtering process for microarray data. Li J; Johnson JA Physiol Genomics; 2002; 9(3):137-44. PubMed ID: 12045294 [TBL] [Abstract][Full Text] [Related]
7. Artificial neural network classifier predicts neuroblastoma patients' outcome. Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577 [TBL] [Abstract][Full Text] [Related]
8. Impact of supervised gene signatures of early hypoxia on patient survival. Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074 [TBL] [Abstract][Full Text] [Related]
9. PCA disjoint models for multiclass cancer analysis using gene expression data. Bicciato S; Luchini A; Di Bello C Bioinformatics; 2003 Mar; 19(5):571-8. PubMed ID: 12651714 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma. Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional adaptation of neuroblastoma cells to hypoxia. Fredlund E; Ovenberger M; Borg K; Påhlman S Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155 [TBL] [Abstract][Full Text] [Related]
13. mtDNA as a Mediator for Expression of Hypoxia-Inducible Factor 1α and ROS in Hypoxic Neuroblastoma Cells. Kuo CW; Tsai MH; Lin TK; Tiao MM; Wang PW; Chuang JH; Chen SD; Liou CW Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590414 [TBL] [Abstract][Full Text] [Related]
14. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia. Cimmino F; Avitabile M; Lasorsa VA; Montella A; Pezone L; Cantalupo S; Visconte F; Corrias MV; Iolascon A; Capasso M BMC Med Genet; 2019 Feb; 20(1):37. PubMed ID: 30808328 [TBL] [Abstract][Full Text] [Related]
15. The L(1/2) regularization approach for survival analysis in the accelerated failure time model. Chai H; Liang Y; Liu XY Comput Biol Med; 2015 Sep; 64():283-90. PubMed ID: 25262114 [TBL] [Abstract][Full Text] [Related]
16. Hydra: A mixture modeling framework for subtyping pediatric cancer cohorts using multimodal gene expression signatures. Pfeil J; Sanders LM; Anastopoulos I; Lyle AG; Weinstein AS; Xue Y; Blair A; Beale HC; Lee A; Leung SG; Dinh PT; Shah AT; Breese MR; Devine WP; Bjork I; Salama SR; Sweet-Cordero EA; Haussler D; Vaske OM PLoS Comput Biol; 2020 Apr; 16(4):e1007753. PubMed ID: 32275708 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors. Ognibene M; Cangelosi D; Morini M; Segalerba D; Bosco MC; Sementa AR; Eva A; Varesio L PLoS One; 2017; 12(11):e0187206. PubMed ID: 29117193 [TBL] [Abstract][Full Text] [Related]
19. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma. Meng X; Feng C; Fang E; Feng J; Zhao X J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778 [TBL] [Abstract][Full Text] [Related]
20. Gene Expression Signatures as Biomarkers of Tumour Hypoxia. Harris BH; Barberis A; West CM; Buffa FM Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):547-60. PubMed ID: 26282471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]